Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
Main Authors: | Kim, Sang Jin, Jeong, Tae Yoong, Yoo, Dae Seon, Park, Jinsung, Cho, Seok, Kang, Seok Ho, Lee, Sang Hyub, Jeon, Seung Hyun, Lee, Tchun Yong, Park, Sung Yul |
---|---|
Format: | Online |
Language: | English |
Published: |
Yonsei University College of Medicine
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630034/ |
Similar Items
-
Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Park, Yong Hyun, et al.
Published: (2014) -
The Clinical Value of Performing an MRI before Prostate Biopsy
by: Choi, Myung Sun, et al.
Published: (2011) -
The diagnostic ability of an additional midline peripheral zone biopsy in transrectal ultrasonography-guided 12-core prostate biopsy to detect midline prostate cancer
by: Hwang, Inpyeong, et al.
Published: (2016) -
The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
by: Kim, Hyung-Sang, et al.
Published: (2012) -
Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy
by: Oh, Jong Jin, et al.
Published: (2016)